WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'4601 Infant (under 12 months) mortality rate: 112
GDP / capita (US$): 12'6431 Child (under 5 years) mortality rate: 122

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 72  71  71  71  71  70  71  75 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years 19  19  19  19  19  18  18  18 

Number of reported case

(Click for retrospective incidence data for Dominica)
Diphtheria
Japanese encephalitis
Measles 13 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Dominica)
Vaccine year result method % card seen                                                
BCG          98  99*  99*  99  98  99  99  65 
DTP1          98  96  97  98  99*  98 
DTP3          97  98  98  100  96  99  92  63 
HepB_BD         
HepB3          97  98  98  100  96 
Hib3          97  98  98  100  96  46 
JapEnc         
MCV          99  99  99*  99*  100  99  88 
MCV2          94  99*  99*  95  99* 
PCV1         
PCV3         
Pol3          97  99*  99  99  95  99  94  53 
Rota1         
Rota_last         
Rubella1          99  99  99*  99*  100 
TT2plus          20 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Dominica)
BCG 98  98  99  99  98  99  99  65 
DTP1 98  99  99  99  96  99  97  84 
DTP3 97  98  98  99  96  99  92  63 
HepB3 97  98  98  99  96 
Hib3 97  98  98  99  96 
MCV 99  99  99  99  99  99  88 
PCV3
Pol3 99  99  99  99  95  99  94  53 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth-1 year; Yes
DT 2, 4, 6 months; DT is given to children unable to have Pertussis
DTwP 18 months; 3 years;
DTwPHibHep 2, 4, 6 months;
HepB Birth; Yes Positive Hep B Mothers. Also given at Y15, +4 weeks, +6 months
Influenza 6 months to 5 years; >= 65 years; Yes High risk
MMR 1, 3 years; Yes
OPV 2, 4, 6, 18 months; 3, 10-12 years; Yes
Td 10-12 years;
YF travelers

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  No  No  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2012      2'009  ongoing  2'007  2'007 
Nº of districts with microplans that include activities to raise immunization coverage number  

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number
Nº districts with DTP3 coverage >=80% number      
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100       
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100% 71  86  100  100       

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  No  Yes  Yes  Yes  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.